Whole Blood Transfusion – The Current State of Developments

Whole-blood transfusion is becoming increasingly important in modern trauma and emergency medicine. While whole blood was largely replaced by component therapy for many decades, new insights into hemorrhagic shock's pathophysiology and extensive military experience have sparked renewed interest in this approach. Whole blood combines red blood cells, plasma, clotting factors, and platelets into one product, addressing key needs for volume replacement and hemostatic therapy in severe hemorrhage. Compared to component therapy, the lower amount of additive solutions may reduce the dilution of circulating blood, potentially improving coagulation, maintaining electrolyte balance, and lowering the risk of transfusion-related circulatory overload. These advantages are particularly significant in military settings, where logistical challenges often restrict access to conventional blood components. Whole blood requires simpler storage and transportation conditions and enables earlier transfusions in resource-limited environments. Concepts like low-titer group O whole blood (LTOWB) further support its use as a readily available universal blood product during emergencies. Additionally, studies demonstrate that cold-stored whole blood retains adequate functional properties for clinically relevant durations. Overall, current evidence suggests that whole blood can be an effective and practical addition to traditional component therapy for managing massive hemorrhage, though further research is needed to establish standardized protocols and evaluate long-term safety and efficacy